Buttock Augmentation in Birmingham United Kingdom

This surgical procedure also called gluteoplasty or buttock augmentation. It is design to reshape the size of your buttocks and create more firm and aesthetic appearance. The buttock area is not easily changed by weight reduction or exercise, therefore you may consider this operation to improve the look of your buttock. In general every person who wishes to undergo the operation and is in a good physical condition can do so.

Buttock augmentation is achieved using fat. The idea is to remove fat from your one body part and inject in into your buttocks. The big advantage of this technique is the fact that there is no rejection since the tissue used is taken from your one body. In addition this method can make your buttock look very natural. The fat is usually taken from areas of the body, which have extra fat, like the flank area, the thigh and the upper and lower buttock. The extra fat, which is removed from the above areas, can further reshape the buttock making it look like you've been through a butt lift. After the fat is removed is undergoes some special processing and then injected to your buttocks using a special cannula, which has a very small diameter therefore leaves minimal scars. The big challenge of the fat grafting is to cause the graft to survive in the new place, this can be achieved by injecting small amount of fat each time into different layers, above and below the butt muscles. This way better blood supply is accomplished and irregularities of the surface is minimized. The graft survival is unpredictable, some of the fat is absorbed causing you to loose the augmentation effect. It is generally believed that what's left after 3 month usually stays forever. After the procedure the buttock area usually don't heart, the pain is generally from the incisions make in the donor area. Those incisions are also very small, the same ones used for liposuction.

Every procedure has its risks, the risks for this one is minimal. The main risk of the procedure is fat absorption, occurring in approximately one-third of the patients. Bleeding, infection and scarring are rare.

You'll be able to go back to work after 3-5 days, but you'll have to wear special garment for 3-4 weeks. It may take up to one month until you feel normal, some swelling may appear, which will usually disappear after a couple of month.

More Birmingham info...


  • Birmingham By car
    Birmingham is well-signposted and surrounded by motorways, including the orbital M42 and the infamous Spaghetti Junction (Gravelly Hill Interchange). Once in the West Midlands:

    From the north, Birmingham is served by A-roads.
    From the north-east, use the M1, M42 and M6.
    From the east, use the M6.
    From the south-east, use the M40 and M42.
    From the south, Birmingham is served by A-roads.
    From the south-west, use the M5 and M42.
    From the west, Birmingham is served by A-roads.
    From the north-west, use the M6.
    Car parks.
    -

  • Birmingham By train
    Birmingham is a major hub of Britain's rail network. The main station is New Street, with Snow Hill and Moor Street carrying significantly fewer services, but including secondary (slower and cheaper) services from London. All three stations are in the city centre and within walking distance of each other and are linked by a free bus service.

    All areas of Britain are well-served, with half-hourly services (Monday-Saturday daytimes) from Bristol, Cardiff, Edinburgh, Glasgow, London, Manchester, Oxford, Sheffield and stations in between. Timetables can be checked at National Rail Enquiries (+44 8457 48 49 50) and booked on-line or over the 'phone through the train operator.
    -

Buttock AugmentationLatest Forum Posts...

  • Yep, butt augmentation is so in these days. I was surprised when I found out that a friend of mine, which is a GUY, had butt implants. Hehe. I just never expected that he'd turn out to be vain after all this time.

Plastic Surgery News...

  • A research team at the Moores Cancer Center at University of California, San Diego (UCSD) reports that patients with chronic lymphocytic leukemia (CLL) who were treated with a gene therapy protocol began making antibodies that reacted against their own leukemia cells.
  • The National Institute for Health and Clinical Excellence (NICE) has published an appraisal consultation document (ACD – draft guidance) on the use of alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. The guidance recommends (direct from source): 1.1 Alendronate is recommended as a treatment option for the secondary prevention of osteoporotic fragility fractures in postmenopausal women who have a T-score of -2.5 SD or below. In women aged 75 years or older, a DXA scan may not be required if the responsible clinician considers it to be clinically inappropriate or unfeasible. When the decision has been made to initiate treatment with alendronate, the preparation prescribed should be chosen on the basis of the lowest acquisition cost available. 1.2 Risedronate and etidronate are recommended as alternative treatment options for the secondary prevention of osteoporotic fragility fractures in postmenopausal women: • who are unable to comply with the special instructions for the administration of alendronate, have a contraindication to, or are intolerant of alendronate (as defined in section 1.7) and • who also have a T-score, age and number of independent clinical risk factors for fracture (see section 1.5) - please refer to table in the ACD for T-scores (SD) at (or below) which risedronate or etidronate is recommended. 1.3 Raloxifene and strontium ranelate are recommended as alternative treatment options for the secondary prevention of osteoporotic fragility fractures in postmenopausal women: • who are unable to comply with the special instructions for the administration of alendronate and risedronate, or who have a contraindication to or are intolerant of alendronate and risedronate (as defined in section 1.6) and • who also have a T-score, age and number of independent clinical risk factors for fracture (see section 1.5) - please refer to table in the ACD for T-scores (SD) at (or below) which raloxifene or strontium ranelate is recommended. 1.4 Teriparatide is recommended as an alternative treatment option for the secondary prevention of osteoporotic fragility fractures in postmenopausal women: • who are unable to take alendronate and risedronate, have a contraindication to, or are intolerant of alendronate and risedronate (as defined in section 1.6) or who have a contraindication to, or are intolerant of strontium ranelate (as defined in section 1.7) and • who are 65 years or older and have an extremely low BMD (with a T-score of -4 SD or below), or a very low BMD (with a T-score of -3.5 SD or below) plus multiple fractures (that is, more than two), or who are aged 55-64 years and have a T-score of -4 SD or below plus multiple fractures (that is, more than two). 1.5 For the purposes of this guidance, independent clinical risk factors for fracture to be considered are: parental history of hip fracture, alcohol intake of 4 or more units per day, and severe, long-term rheumatoid arthritis. 1.6 For the purposes of this guidance, intolerance of alendronate and risedronate is defined as persistent upper gastrointestinal disturbance that is sufficiently severe to warrant discontinuation of treatment and that occurs even though the instructions for administration have been followed correctly. 1.7 For the purpose of this guidance, intolerance of strontium ranelate is defined as persistent nausea or diarrhoea, either of which warrants discontinuation of treatment. 1.8 Women who are currently receiving treatment with one of the drugs covered by this guidance, but for whom therapy would have not been recommended according to sections 1.1 to 1.4, should have the option to continue therapy until they and their clinicians consider it appropriate to stop. The key dates for this appraisal are: Closing date for comments: 23 April 2008 Second Appraisal Committee meeting: 01 May 2008

Ask A Local Surgeon
From Birmingham

»Have a Local Immersivemedical member contact you«

Buttock Augmentation Surgeons in Birmingham

Your Clinic NameYour Clinic Name
Join us and get your clinic listed here.
also join our referral system and get referring customers in your area.

..



»Add Your clinic Here«»Recommend a Clinic«

Plastic Surgery Articles


»Add Your Article«


Buttock Implants in Birmingham, Eyelid Surgery in Birmingham, Body Contouring in Birmingham, Botox® Cosmetic in Birmingham, Breast Augmentation in Birmingham, Breast Reduction in Birmingham, Buttock Augmentation in Birmingham, Chemical Peel in Birmingham, Chin Augmentation in Birmingham, Correction Of Breast Asymmetry in Birmingham, Ear Surgery in Birmingham, Facelift in Birmingham, Fat Grafting in Birmingham, Gastric Bypass in Birmingham, Hair Replacement in Birmingham, Jaw Surgery in Birmingham, Lip Augmentation in Birmingham, Liposuction in Birmingham, Male Breast Reduction in Birmingham, Neck Lift in Birmingham, Penis Enlargement in Birmingham, Spider Vein Treatment in Birmingham, Breast Reconstruction in Birmingham, Nose Reshaping in Birmingham, Dermabrasion in Birmingham, Vaginal Surgery in Birmingham, Medical Tourism in Birmingham, Plastic Surgeon in Birmingham, Arm Lift in Birmingham, Tummy Tuck in Birmingham, Hyperhydrosis in Birmingham, Nose Surgery in Birmingham, Hair Transplant in Birmingham, Cellulite Treatment in Birmingham, Hair Removal in Birmingham, Tattoo Removal in Birmingham, Cheek Augmentation in Birmingham, Inverted Nipple Repair in Birmingham, Skin Resurfacing in Birmingham, Body Procedures in Birmingham, Permanent Cosmetics in Birmingham, Face Procedures in Birmingham, Skin Surgery1 in Birmingham, Calf Augmentation in Birmingham, Birthmark Removal in Birmingham